nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

23.10.2015 | Head and Neck

Minor salivary gland carcinoma: a review of 35 cases

verfasst von: Georg Haymerle, Sven Schneider, Luke Harris, Theresia Häupl, Christian Schopper, Johannes Pammer, Matthaeus Ch. Grasl, Boban M. Erovic

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Minor salivary gland carcinomas represent a heterogeneous group of tumors with broad variation in clinical appearance and histopathology. Clinical data of patients with small salivary gland malignancies were collected from the medical records. Tissue microarray was constructed to determine the expression pattern of 24 proteins in 35 patients with minor salivary gland carcinomas. The choice of markers was based on involvement in neoangiogenesis, cell-to-cell contact, cell-cycle regulation and carcinogenesis. Protein expression data were correlated to patients’ clinical data. Overexpression of patched (p = 0.046) and Smo (p = 0.032) was linked to a better overall survival and Glutathione S-transferase π overexpression was linked to prolonged disease-free survival (p = 0.005). Cox-1 (p = 0.035) and VEGFR2 (p = 0.009) were significantly linked to decreased survival for recurrent disease. Bcl-x (84 %), β-catenin (87 %) and Cox-2 (87 %) were significantly overexpressed in minor salivary gland carcinomas. We have shown that Smo resulted in a better overall survival, whereas Gstπ in improved disease-free survival. VEGFR2 was a prognostic factor for survival after recurrence in patients with minor salivary gland carcinomas. Cyclooxygenase inhibitors and anti-Wnt-1 antibodies might be a potential therapeutic option in an adjuvant setting or for patients with unresectable tumors of the minor salivary glands.

Lopes MA, Santos GC, Kowalski LP (1998) Multivariate analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 20:699–706CrossRefPubMed

Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. World Health Organization classification of tumours. IARC Press, Lyon

Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR (1996) Management of minor salivary gland carcinomas. Int J Rad Oncol Biol Phys 35:443–454CrossRef

Carrillo JF, Maldonado F, Carrillo LC, Ramirez-Ortega MC, Pizano JG, Melo C et al (2011) Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx. Head Neck 33:1406–1412CrossRefPubMed

Patel KJ, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM (2006) Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. Oral Oncol 42:994–1004CrossRefPubMed

Russo G, Zamparelli A, Howard CM, Minimo C, Bellan C, Carillo G et al (2005) Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. Clin Cancer Res 11:3265–3273CrossRefPubMed

Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS et al (2008) Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res 14:5181–5187CrossRefPubMed

Miyabe S, Okabe M, Nagatsuka H, Hasegawa Y, Inagaki A, Ijichi K et al (2009) Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases. J Oral Maxillofac Surg 67:1432–1441CrossRefPubMed

Erovic BM, Schopper C, Pammer J, Vormittag L, Maleki A, Brunner M et al (2010) Multimodal treatment of patients with minor salivary gland cancer in case of recurrent disease. Head Neck 32:1167–1172CrossRefPubMed

10.

Jaskoll T, Leo T, Witcher D, Ormestad M, Astorga J, Bringas P Jr et al (2004) Sonic hedgehog signaling plays an essential role during embryonic salivary gland epithelial branching morphogenesis. Dev Dyn 229:722–732CrossRefPubMed

11.

Schneider S, Thurnher D, Kloimstein P, Leitner V, Petzelbauer P, Pammer J et al (2011) Expression of the Sonic hedgehog pathway in squamous cell carcinoma of the skin and the mucosa of the head and neck. Head Neck 33:244–250CrossRefPubMed

12.

Kim TJ, Lee JY, Hwang TK, Kang CS, Choi YJ (2011) Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups. J Surg Oncol 104:472–479CrossRefPubMed

13.

Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369–7375CrossRefPubMed

14.

Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K (2008) Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Hepatogastroenterology 55:1530–1536PubMed

15.

Kumaraguruparan R, Chandra Mohan KV, Nagini S (2006) Xenobiotic-metabolising enzymes in patients with adenocarcinoma of the breast: correlation with clinical stage and menopausal status. Breast 15:58–63CrossRefPubMed

16.

de Santa Carrillo, Pau E, Arias FC, Caso Peláez E, Muñoz Molina GM, Sánchez Hernández I, Muguruza Trueba I et al (2009) Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer. Cancer 115:1701–1712CrossRef

17.

Kim JJ, Vaziri SA, Rini BI, Elson P, Garcia JA, Wirka R et al (2011) Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib. Cancer 118:1946–1954CrossRefPubMedPubMedCentral

18.

Erovic BM, Woegerbauer M, Pammer J, Selzer E, Grasl MCh, Thurnher D (2008) Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer. Eur J Clin Invest 38:61–66CrossRefPubMed

19.

Erovic BM, Pelzmann M, Turhani D, Pammer J, Niederberger V, Neuchrist C et al (2003) Differential expression pattern of cyclooxygenase-1 and -2 in head and neck squamous cell carcinoma. Acta Otolaryngol 123:950–953CrossRefPubMed

20.

Loh KS, Barker E, Bruch G, O’Sullivan B, Brown DH, Goldstein DP et al (2009) Prognostic factors in malignancy of the minor salivary glands. Head Neck 1:58–63CrossRef

21.

Bradley PJ (2004) Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 12:127–132CrossRefPubMed

22.

Le QT, Birdwell S, Terris DJ et al (1999) Postoperative irradiation of minor salivary gland malignancies of the head and neck. Radiother Oncol 52:165–171CrossRefPubMed

23.

Surakanti SG, Agulnik M (2008) Salivary gland malignancies: the role for chemotherapy and molecular targeted agents. Semin Oncol 35:309–319CrossRefPubMed

24.

Lo Russo L, Lo Muzio L (2009) Combination chemotherapy for head and neck cancer: the addition of Bcl-2 inhibitors. Curr Opin Investig Drugs 10:1325–1333PubMed

25.

Johnson ML, Rajamannan N (2006) Diseases of Wnt signaling. Rev Endocr Metab Disord 7:41–49CrossRefPubMedPubMedCentral

26.

Wei W, Chua MS, Grepper S, So SK (2009) Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer 8:76CrossRefPubMedPubMedCentral

27.

Couzin J (2004) Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science 306:384–385CrossRefPubMed

28.

Terhaard CH, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA et al (2004) Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26:681–692CrossRefPubMed

29.

Chang JW, Hong HJ, Ban MJ, Shin YS, Kim WS, Koh YW et al (2015) Prognostic factors and treatment outcomes of parotid gland cancer: a 10-year single-center experience. Otolaryngol Head Neck Surg (Epub ahead of print)

Titel: Minor salivary gland carcinoma: a review of 35 cases
verfasst von: Georg Haymerle
Sven Schneider
Luke Harris
Theresia Häupl
Christian Schopper
Johannes Pammer
Matthaeus Ch. Grasl
Boban M. Erovic
Publikationsdatum: 23.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 9/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-015-3805-4

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Minor salivary gland carcinoma: a review of 35 cases

Abstract

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2016

Clinical and surgical implications regarding morphometric variations of the medial wall of the orbit in relation to age and gender

Postoperative antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery: a retrospective cohort study

The effect of symmetrical and asymmetrical hearing impairment on music quality perception

The long-term fate of epistaxis patients with exposure to antithrombotic medication

Short, sharp shock public health campaign had limited impact on raising awareness of laryngeal cancer

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO